Statistically significant differences were found in our analyses of groups of patients with BPH and US, as well as in the C1 group, for UPIIIa and UPII in both urine and plasma (one-way ANOVA test), (Table 2). The gene discussed is UPK3A; the disease is benign prostatic hyperplasia.